Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
12/21/1990 | WO1990015793A1 Novel polystyrenesulfonate |
12/21/1990 | WO1990015792A1 Novel cyclodextrin inclusion complexes |
12/21/1990 | CA2059282A1 Polystyrenesulfonate |
12/21/1990 | CA2058996A1 Cyclodextrin inclusion complexes |
12/21/1990 | CA2058941A1 Stereoisomers |
12/21/1990 | CA2019482A1 Process for the preparation of 4-acyloxyazetidin-2-one by electrochemical methods |
12/21/1990 | CA2019479A1 Process for the preparation of 4-acyloxyazetidin-2-one by singlet oxygen oxidation |
12/21/1990 | CA2019472A1 Nutritional formulation for the treatment of renal disease |
12/21/1990 | CA2019464A1 Bis (benzylpyrrolidine) derivatives as dopamine agonists |
12/20/1990 | WO1990015599A1 Medicaments useful in cancer therapy and having antihistaminic properties |
12/20/1990 | DE4017172A1 Elimination of xenobiotics ex vivo - by topical or oral treatment with squalane or squalene |
12/20/1990 | DE3919644A1 Organic and/or inorganic polymers - have anionic gps. bound to carrier, used for prophylaxis and treatment of viral infections |
12/20/1990 | CA2059127A1 Medicaments useful in cancer therapy and having antihistaminic properties |
12/20/1990 | CA2019432A1 1,1-dioxopenicil-lanoyloxymethyl d-6-[ -(methyleneamino)phenylacetamido] penicillanate and a process for the preparation thereof |
12/20/1990 | CA2019315A1 Anthracycline derivatives, a process for the preparation thereof and the use thereof as a pharmaceutical |
12/20/1990 | CA2019251A1 R(-)3-quinuclidinol derivatives |
12/20/1990 | CA2019171A1 Use of 3-hydroxybenzothiophenes for combating endoparasites, new 3-hydroxybenzothiophenes and processes for their preparation |
12/19/1990 | EP0403398A1 New thioformamide derivatives |
12/19/1990 | EP0403383A1 Sustained release pharmaceutical formulations |
12/19/1990 | EP0403377A1 Sulfated polysaccharides, anticoagulant and anticomplementary agent prepared from fucans from brown seaweeds and process for obtaining them |
12/19/1990 | EP0403360A2 Use of phenylethanolamines for the preparation of a medicament for treating ophthalmologic disorders |
12/19/1990 | EP0403318A1 Process for the preparation of an anti-tumor substance, 3-amino-1-(2-amino-1H-imidazolyl-4)-2-chloro-1-propanol and his salts in the threo-racemic-form, for use as a medicament |
12/19/1990 | EP0403301A2 Aerosols of pyrido[1,2-a]pyrimidine compounds |
12/19/1990 | EP0403300A1 N-Phenylpyrazole derivatives |
12/19/1990 | EP0403271A2 Polymer compounds |
12/19/1990 | EP0403261A2 Amide derivatives |
12/19/1990 | EP0403251A2 Monokine activity interference |
12/19/1990 | EP0403249A1 Leukotriene antagonists |
12/19/1990 | EP0403242A1 New L-683,590 microbial transformation product |
12/19/1990 | EP0403199A2 Compounds |
12/19/1990 | EP0403198A2 Compounds |
12/19/1990 | EP0403185A2 Compounds having one or more aminosulfonyloxy radicals useful as pharmaceuticals |
12/19/1990 | EP0403159A2 Imidazolyl-alkenoic acids |
12/19/1990 | EP0403158A2 Imidazolyl-alkenoic acids |
12/19/1990 | EP0403150A2 Process for the preparation of tigogenin beta-cellobioside |
12/19/1990 | EP0403090A1 7-oxabicycloheptane imidazole prostaglandin analogs useful in the treatment of thrombotic and vasopastic disease |
12/19/1990 | EP0403048A2 Medicated compositions containing sucralfate and processes for their production |
12/19/1990 | EP0402989A2 Antifungal 4-[4-[4-[4-[[2-(2,4-difluorophenyl)-2-(1H-azolylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]triazolones and imidazolones |
12/19/1990 | EP0402950A2 Treatment of postmenopausal disorders |
12/19/1990 | EP0402933A2 Use of sucralfate humid gel as vehicle for drugs having topic activity and for cosmetics |
12/19/1990 | EP0402931A1 Heteroatoms-containing tricyclic compounds |
12/19/1990 | EP0402923A2 2,5-Diaminotetralines, process for their preparation and their use as medicine |
12/19/1990 | EP0402903A1 Production of pyrrolopyrimidines and intermediates therefor |
12/19/1990 | EP0402862A2 Novel cyclic anthranilic acid acetic acid derivatives and process for their preparation |
12/19/1990 | EP0402859A2 Therapeutic agents of metabolic bone disease |
12/19/1990 | EP0402858A2 Melanogenesis-inhibiting preparation for external application |
12/19/1990 | EP0402857A2 Use of 17 beta-Cyclopropylaminoandrostene Derivatives |
12/19/1990 | EP0402807A2 7H-benzo (b)pyrazino(1,2-d)pyrrolo(3,2,1-jk)(1,4)benzodiazepines, a process for their preparation and their use as medicaments |
12/19/1990 | EP0402806A1 Crystalline cephem-acid addition salts and process for preparing them |
12/19/1990 | EP0402805A1 Lyophilized preparation of 6-(3-dimethylaminopropionyl)forskolin |
12/19/1990 | EP0402776A2 Melanogenesis-inhibiting preparation for external application |
12/19/1990 | EP0402755A2 L-carnitine magnesium citrate |
12/19/1990 | EP0402752A1 N-heteroaryl-purin-6-amines, a process for their preparation and their use as medicaments |
12/19/1990 | EP0402734A2 Composition for the treatment of application of the central nervous system and to enhance cerebral perfusion |
12/19/1990 | EP0402733A2 Agent for the treatment of central nervous system illnesses and for the enhancement of cerebral blood flow |
12/19/1990 | EP0402724A1 Hydroxyethyl starch as plasma expander and process for its preparation |
12/19/1990 | EP0402646A1 Retroviral protease inhibiting compounds |
12/19/1990 | EP0402644A1 N-(aryloxyalkyl)heteroarylpiperidines and -heteroarylpiperazines,a process for their preparation and their use as medicaments |
12/19/1990 | EP0402637A2 Stable freeze dried polyhematoporphyrin ether/ester composition |
12/19/1990 | EP0402477A1 Use of isocarbacyclins for preventing or treating organ diseases |
12/19/1990 | EP0402422A1 Certain paf antagonist antihistamine combinations and methods |
12/19/1990 | EP0402369A1 Solubilization of complexes of water-insoluble organic compounds by aqueous solutions of polyvinylpyrrolidone |
12/19/1990 | EP0211023B1 Pharmaceutical composition containing ubidecarenone |
12/19/1990 | CN1047869A Acylated derivatives of etoposide |
12/19/1990 | CN1047866A Process for preparation of n-heteroaryl-purin-6-amines and their use as medicaments |
12/19/1990 | CN1047865A Process for preparing antifungal triazolones and imidazolones derivs. |
12/19/1990 | CN1047863A 3-keto hmg-co a reductase inhibitors |
12/19/1990 | CN1047860A Butenoic acid derivatives |
12/19/1990 | CN1047857A 2-hydroxy-3-phenoxypropylamino derivs. and their preparation |
12/19/1990 | CN1047805A New process for extracting polystictus versicolor polysaccharose |
12/19/1990 | CN1047803A Etoposide preparations |
12/19/1990 | CN1047802A Moisturing vehicle for topical application of vitamin a acid |
12/19/1990 | CN1047801A Preparation of ibuprofen injection for animals |
12/19/1990 | CN1010855B Process for preparation of benzopyran derivs. |
12/19/1990 | CA2019200A1 Cyclic anthranilic acid carboxylic acid derivatives |
12/19/1990 | CA2019156A1 Formation of triple helix complexes of double stranded dna using nucleoside oligomers |
12/18/1990 | US4978783 2,6-dimethoxyhydroquinone-3-mercaptopropionic acid, 2,6-dimethoxyhydroquinone-3-mercaptoacetic acid, and antitumor use thereof |
12/18/1990 | US4978773 Process for the preparation of 2,6-dichlorodiphenylaminoacetic acid derivatives |
12/18/1990 | US4978772 Utilization of otilonium bromide (DCI) for topical application in the gastroinstestinal tract and related pharmaceutical formulation appropriate for such use |
12/18/1990 | US4978767 Diphenylethylene derivative and pharmaceutical use |
12/18/1990 | US4978762 Process for preparing [1S-[1α,2α)Z),3α,4α]]-7-[3-[[[[[1-oxoheptyl]-amino]acetyl]amino]methyl]-7-oxabicyclo-[2,2,1]hept-2-yl]-5-heptenoic acid |
12/18/1990 | US4978761 Enzyme inhibitors |
12/18/1990 | US4978752 Stable, water soluble |
12/18/1990 | US4978688 Method of treating white blood cells |
12/18/1990 | US4978687 Anti-viral agent |
12/18/1990 | US4978684 Method and agents for preventing staining of teeth |
12/18/1990 | US4978683 Administering to humans having pancreatic, colic or gastric tumors whose growth is increased by bioactive polypeptides |
12/18/1990 | US4978681 Aliphatic carboxyic acid, salt or glyceride with odd number of carbon atoms |
12/18/1990 | US4978680 Treating patients with 2-phenyl 1,3-propanediol dicarbamate |
12/18/1990 | US4978679 6- and/or 7-substituted-1,2,3,4,4A,9B-hexahydro-8-hydroxydibenzofuran-3-ols as inhibitors of leukotriene biosynthesis |
12/18/1990 | US4978677 Pesticides |
12/18/1990 | US4978676 Treatment of skin diseases with artemisinin and derivatives |
12/18/1990 | US4978675 Macrolide antibiotics and their preparation |
12/18/1990 | US4978674 Daimine derivatives, and method of manufacturing the same |
12/18/1990 | US4978673 Organic salts of physostigmine derivatives |
12/18/1990 | US4978671 Thieno (3',4'-4,5)imidazo(2,1-b)thiazole derivatives, a process for their preparation and their use in medicaments |
12/18/1990 | US4978670 Anthelmintic quaternaryalkyl acylhydrazones, method of use and compositions |
12/18/1990 | US4978669 Method of suppressing appetite by administration of tetrahydro-beta-carboline derivatives |
12/18/1990 | US4978668 Treatment to reduce ischemic tissue injury |
12/18/1990 | US4978667 Substituted 6H-7,8-dihydrothiapyrano(3,2-d)-pyrimidines as hypoglycemic agents |